Join our Investor Webinar on the 3rd December 18:00-19:30, with speakers from Sunda Energy and Blencowe Resources. Please register here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.48
Bid: 13.82
Ask: 14.48
Change: 0.86 (6.31%)
Spread: 0.66 (4.776%)
Open: 14.50
High: 14.50
Low: 14.48
Prev. Close: 13.62

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Press speculation

27 Nov 2023 07:00

RNS Number : 6718U
Revolution Beauty Group PLC
27 November 2023
 

27 November 2023

 

Revolution Beauty Group plc

("Revolution Beauty", the "Group" or the "Company")

 

Press speculation

 

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, notes the recent press speculation regarding potential agreements with the Group's former Chief Executive Officer (CEO), Adam Minto, and former Executive Chairman, Tom Allsworth.

 

As previously announced on 20 June 2023, the Group announced potential legal proceedings against Mr Minto regarding the events that led to a delay in the audit of the FY22 results and the suspension of the Company's shares from trading on AIM.

 

Separately, and as previously announced on 31 August 2023, the Board is negotiating with Tom Allsworth, the previous owner of Medichem, to reach a revised agreement on the terms of its acquisition. 

 

Revolution Beauty remains in negotiation on both these issues. There is no guarantee that agreements will be reached. Should agreements be reached, they would likely be treated as related party transactions and an appropriate announcement made at that time.

 

For further information please contact:

 

Investor Relations

Lauren Brindley, CEO

Elizabeth Lake, CFO

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

Zeus (NOMAD): Nick Cowles / Jamie Peel / Jordan Warburton

Tel: +44 (0) 161 831 1512

 

Liberum: Dru Danford / Edward Thomas / John More / Miquela Bezuidenhoudt

Tel: +44 (0) 203 100 2222

 

Media enquiries

Headland Consultancy: Matt Denham / Will Smith / Antonia Pollock

Tel: +44 (0)20 3805 4822

Revolutionbeauty@headlandconsultancy.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCZZMZMRVRGFZM
Date   Source Headline
8th Nov 20247:00 amRNSNotice of HY25 Results
4th Nov 20247:00 amRNSNominated Adviser and Broker
4th Nov 20247:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSHY2025 Trading Update
7th Oct 202412:40 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSRelated party transactions
5th Sep 20244:56 pmRNSHolding(s) in Company
30th Aug 20244:11 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20244:59 pmRNSAnnual General Meeting
29th Jul 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jul 20247:00 amRNSNotice of Retail Investor Presentation
3rd Jul 20245:00 pmRNSNotice of AGM and posting of Annual Report
1st Jul 202412:00 pmRNSTotal Voting Rights and NOMAD name change
26th Jun 20247:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 29 FEBRUARY 2024
17th Jun 20247:00 amRNSNotice of FY24 Results
30th Apr 20244:59 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSHolding(s) in Company
22nd Apr 20249:09 amRNSResponse to allegations by Chrysalis Investments
12th Apr 20244:43 pmRNSHolding(s) in Company
4th Apr 20247:01 amRNSHolding(s) in Company
4th Apr 20247:00 amRNSHolding(s) in Company
3rd Apr 20249:40 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSTrading Update
11th Mar 20241:50 pmRNSTotal Voting Rights
20th Feb 20247:00 amRNSGrant of Share Options
19th Feb 20247:00 amRNSChange of Auditor
8th Feb 20247:00 amRNSCapital Markets Event and FY24 Trading Update
5th Feb 20247:00 amRNSAdam Minto Settlement Agreement
2nd Feb 20247:00 amRNSResponse to allegations by Chrysalis Investments
26th Jan 20247:00 amRNSBlock Admission Application
24th Jan 20247:00 amRNSNotice of Capital Markets Event
13th Dec 20237:00 amRNSDirectorate changes and settlement agreement
8th Dec 20237:00 amRNSChange of Adviser & Rule 17 Schedule Two(g) Update
27th Nov 20237:00 amRNSPress speculation
22nd Nov 20237:18 amRNSHolding(s) in Company
14th Nov 20231:29 pmRNSHolding(s) in Company
14th Nov 20231:25 pmRNSHolding(s) in Company
14th Nov 20231:23 pmRNSHolding(s) in Company
14th Nov 20237:00 amRNSInterim Results
9th Nov 20231:21 pmRNSNotice of Interim Results
31st Oct 20236:08 pmRNSHolding(s) in Company
31st Oct 20236:07 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
31st Oct 20236:06 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSResults of AGM
19th Sep 20237:00 amRNSGrant of Share Options
13th Sep 20232:44 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of AGM and posting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.